Gelteq Limited Ordinary Shares

GELS XNAS

Market Cap

5.2M

Short interest (May 15)

1.1%

Net Short (Jun 03 ): 0.0%

Borrow Fee

78.55%

↓ 13.1%

Available Shares

200K

↓ 17.9%

Price Chart

Company Overview

Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.

Company Info

Exchange: NASDAQ
CIK: 0001920092
Asset Type: CS

Market Data

Market Cap: $5,185,416
Employees: 8
Status: Active

Short Interest

Current Borrow Fee 78.55%
Range: 78.55% - 78.55%
Available Shares 200K
Range: 100K - 150K

Recent Changes

Fee Change: ↑ 0.7%
Available Change: ↓ 16.7%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime